Watts Chad D, Houdek Matthew T, Wagner Eric R, Abdel Matthew P, Taunton Michael J
Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota.
J Arthroplasty. 2016 Jan;31(1):256-9. doi: 10.1016/j.arth.2015.08.026. Epub 2015 Aug 30.
The aims of this study were to compare the outcomes between nondiabetic (n=1284), type II diabetic (n=530), and insulin-dependent type II diabetic (n=164) morbidly obese (body mass index ≥40 kg/m(2)) patients undergoing primary total knee arthroplasty at 6-year follow-up. Patients with type II diabetes mellitus (DM) had similar outcomes when compared with non-DM patients. However, patients with insulin dependence had an increased risk of reoperation (hazard ratio [HR], 1.8; P=.005), revision (HR, 2; P=.02), and periprosthetic joint infection (HR, 2.1; P=.03), as well as decreased 10-year implant survivorship (84% vs 92%; P=.01) when compared to non-DM patients. Prospective studies should further evaluate outcomes and optimization measures within this population.
Level III-prognostic study.
本研究旨在比较非糖尿病(n = 1284)、II型糖尿病(n = 530)和胰岛素依赖型II型糖尿病(n = 164)的病态肥胖(体重指数≥40 kg/m²)患者在接受初次全膝关节置换术后6年随访的结果。与非糖尿病患者相比,II型糖尿病(DM)患者的结果相似。然而,与非糖尿病患者相比,胰岛素依赖型患者再次手术风险增加(风险比[HR],1.8;P = 0.005)、翻修风险增加(HR,2;P = 0.02)、假体周围关节感染风险增加(HR,2.1;P = 0.03),且10年植入物生存率降低(84%对92%;P = 0.01)。前瞻性研究应进一步评估该人群的结果和优化措施。
III级 - 预后研究。